返回
HBM Holdings Limited（2142.HK）价格
2142.HK 股价走势图
HBM HOLDINGS-B (2142.HK)
HBM Holdings Limited
HK$14.38
-1.03%
$-0.14
休市： Jan 16, 16:00:00 HKT
关键数据
前收盘价
$14.53
开盘价
$14.53
当日区间
$14.08 - $14.68
52周范围
$2.9 - $17.98
交易量
2.8M
平均成交量
4.4M
每股收益（TTM）
0.73
股息收益率
--
市值
$12.0B
什么是 HBM HOLDINGS-B？
HBM Holdings Ltd. is an investment company, which engages in the discovery and development of differentiated antibody therapeutics in oncology and immunology disease areas. The company is headquartered in Suzhou, Jiangsu and currently employs 210 full-time employees. The company went IPO on 2020-12-10. The Company’s products primarily include BATOCLIMAB (HBM9161), HBM9378, HBM7020, TCE Program, PORUSTOBART (HBM4003), HBM7022 and others. The products are primarily used to treat generalized myasthenia gravis (gMG), chronic obstructive pulmonary disease (COPD), asthma, autoimmune diseases, melanoma, colorectal carcinoma (CRC) and solid tumors. The firm provides next-generation antibody and biotherapeutic solutions through proprietary antibody technology platforms including Harbour Mice, HBICE, HBICA and single B cell cloning platform.